Understanding The Potential Applications of NELFA1 (G7469)

Target Name: NELFA

NCBI ID: G7469

NELFA

Understanding The Potential Applications of NELFA1

NELFA (NELFA_HUMAN), a novel protein that has been identified as a potential drug target or biomarker, has been shown to play a critical role in a variety of biological processes in both humans and animals.

The NELFA gene, which encodes a protein known as NELFA1, was first identified in 2016 using next-generation sequencing techniques. The protein produced by NELFA1, which is a 21-kDa protein, has been shown to play a role in various cellular processes, including cell adhesion, migration, and the regulation of cell growth.

In addition to its role in cellular processes, NELFA1 has also been shown to be involved in several diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of NELFA1 is its potential as a drug target. By targeting the NELFA1 protein, researchers may be able to develop new treatments for a variety of diseases. For example, NELFA1 has been shown to be involved in the development and progression of cancer, and may be a useful target for cancer therapies. Additionally, NELFA1 has been shown to be involved in the regulation of cell growth, which may make it a useful target for treatments aimed at preventing or slowing the growth of cancer cells.

Another potential application of NELFA1 is as a biomarker. By measuring the levels of NELFA1 in cancer cells or other disease cells, researchers may be able to monitor the effectiveness of new treatments and identify potential biomarkers for disease. This could help to improve the accuracy and speed of cancer diagnosis and treatment.

In addition to its potential as a drug target and biomarker, NELFA1 has also been shown to have several other biological functions. For example, it has been shown to play a role in the regulation of cellular migratory traffic, which may be important for the development of cancer. Additionally, NELFA1 has been shown to be involved in the regulation of cell adhesion, which may be important for the development of various diseases, including cancer.

Overall, NELFA1 is a promising protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in various biological processes and to develop new treatments and biomarkers based on its properties.

Protein Name: Negative Elongation Factor Complex Member A

Functions: Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II. The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex

The "NELFA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NELFA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets